Home
/ Ethris
/ Competitors

Ethris Competitors and Similar CompaniesClear all

Ethris's competitors and similar companies include Ocugen, Asklepios BioPharmaceutical and ProQR Therapeutics.

	Ethris Ethris is a biopharmaceutical company focused on developing therapies for pulmonary diseases such as primary ciliary dyskinesia.	Ocugen Ocugen is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing therapies to treat eye diseases	Asklepios BioPharmaceutical Asklepios BioPharmaceutical is engaged in the development and delivery of novel protein.	ProQR Therapeutics ProQR Therapeutics is a company that develops RNA therapies designed for patients suffering from genetic rare diseases.
Founding Date	Founding Date 2009	Founding Date 2013	Founding Date 2001	Founding Date 2012
Type	Type Private	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech genetics pharma therapy	Tags Healthcare biotech genetics pharma therapy	Tags Healthcare biotech genetics pharma therapy	Tags Healthcare biotech genetics pharma therapy
Locations	Locations Planegg, DE HQ	Locations Malvern, US HQ	Locations Chapel Hill, US HQ Roslin, GB	Locations Leiden, NL HQ Cambridge, US
Employees	Employees 504% decrease	Employees 84425% increase	Employees 5172% increase	Employees 166
Valuation ($)	Valuation ($) N/A	Valuation ($) 292.1 m	Valuation ($) N/A	Valuation ($) 281.8 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $4.4m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) €15.9m (FY, 2025)
Net income	Net income N/A	Net income ($67.8m) (FY, 2025)	Net income N/A	Net income (€42.2m) (FY, 2025)
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 235m	Total funding raised $ 57.8m